Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Senseonics Holdings, Inc.SENS · Entity 5469 | Director · Chief Commercial Officer | June 15, 2026 | June 17, 2026 |
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP & CHIEF COMMERCIAL OFFICER | November 27, 2023 | November 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Senseonics Holdings, Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 126,937 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Tax withholding · Disposed 5,420 · Balance 126,937 F1: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.
TANDEM DIABETES CARE INC
Report date November 27, 2023 · Filed November 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,622 |
Ending reported balance
After 2023-11-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-27 · Exercise / conversion · Acquired 406 · Balance 12,757 Row 2 · 2023-11-27 · Tax withholding · Disposed 135 · Balance 12,622 F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 813 |
Reported balance
After 2023-11-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-11-27 · Exercise / conversion · Disposed 406 · Balance 813 F2: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 4,986 | $0.00 Strike: $51.50 | $0.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · derivative · entry 10 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,014 Underlying: Common Stock · 4,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 25,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · derivative · entry 9 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 9,146 | $0.00 Strike: $69.50 | $0.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · derivative · entry 8 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,146 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested as to twenty-five percent (25%) of the underlying shares on 12/16/2017, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 4,986 | $112.89 | $562,859.07 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 7 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020. F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.75 and $113.42.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,986 | $51.50 | $256,779.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 6 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 200 | $112.18 | $22,436.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 5 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.18 and $112.19.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 23,731 | $111.48 | $2,645,451.19 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 4 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,865 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.78 and $111.72.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,215 | $110.32 | $1,126,957.62 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,596 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.78 and $110.76.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 25,000 | $18.86 | $471,500.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 9,146 | $69.50 | $635,647.00 |
DisclosureSEC source: 0001438133-20-000139 · wf-form4_159925221488378.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 8,320 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · derivative · entry 11 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,180 Underlying: Common Stock · 8,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vested as to twenty-five percent (25%) of the underlying shares on 05/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 4,354 | $0.00 Strike: $69.50 | $0.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · derivative · entry 10 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,146 Underlying: Common Stock · 4,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vested as to twenty-five percent (25%) of the underlying shares on 02/16/2017, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 11,280 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · derivative · entry 9 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested as to fifty percent (50%) of the underlying shares on 12/16/2017, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 8,320 | $106.11 | $882,809.41 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 8 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.00 and $106.50. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 8,320 | $9.00 | $74,880.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 7 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 4,354 | $106.55 | $463,913.04 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 6 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.51 and $106.65. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,354 | $69.50 | $302,603.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 5 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 3,400 | $105.99 | $360,352.06 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 4 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $105.84 and $106.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 3,400 | $23.00 | $78,200.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 7,880 | $105.16 | $828,689.96 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $104.84 and $105.83.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 00:07 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 7,880 | $23.00 | $181,240.00 |
DisclosureSEC source: 0001438133-20-000121 · wf-form4_159658603830767.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| May 27, 2020 Filed May 30, 2020 00:44 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 15,012 | $0.00 Strike: $82.34 | $0.00 |
DisclosureSEC source: 0001438133-20-000072 · wf-form4_159079947054567.xml · derivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,012 Underlying: Common Stock · 15,012 shares Expires not disclosed F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 27, 2020 Filed May 30, 2020 00:44 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 6,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000072 · wf-form4_159079947054567.xml · derivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,504 Underlying: Common Stock · 6,504 shares Expires not disclosed F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 15, 2020 Filed May 20, 2020 00:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 1,255 | $16.93 | $21,247.15 |
DisclosureSEC source: 0001438133-20-000059 · wf-form4_158993501812795.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 20,945 | $77.62 | $1,625,652.46 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 8 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $77.51 and $77.77. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 20,945 | $18.86 | $395,022.70 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 7 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 0 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · derivative · entry 9 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,000 | $72.78 | $727,842.00 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 6 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $72.76 and $73.13. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 10,000 | $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 5 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 15,000 | $74.82 | $1,122,300.00 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 4 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $74.76 and $74.90. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 15,000 | $18.86 | $282,900.00 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 4,055 | $77.51 | $314,303.05 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,055 | $18.86 | $76,477.30 |
DisclosureSEC source: 0001438133-20-000008 · wf-form4_158051325814661.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 23:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001438133-20-000002 · wf-form4_157930543731668.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 23:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,000 | $69.76 | $697,620.00 |
DisclosureSEC source: 0001438133-20-000002 · wf-form4_157930543731668.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $69.76 and $69.77. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 23:57 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000002 · wf-form4_157930543731668.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001438133-19-000020 · wf-form4_157307838319846.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 15,000 | $62.01 | $930,130.50 |
DisclosureSEC source: 0001438133-19-000020 · wf-form4_157307838319846.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16,2019. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $61.75 and$62.26. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 15,000 | $2.59 | $38,850.00 |
DisclosureSEC source: 0001438133-19-000020 · wf-form4_157307838319846.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 6,969 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001209191-19-047601 · doc4.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 6,969 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 6,969 | $70.00 | $487,830.00 |
DisclosureSEC source: 0001209191-19-047601 · doc4.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16, 2019. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 20:09 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 6,969 | $18.86 | $131,435.34 |
DisclosureSEC source: 0001209191-19-047601 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-19-045769 · doc4.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 15,000 | $62.97 | $944,550.00 |
DisclosureSEC source: 0001209191-19-045769 · doc4.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16, 2019. F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.70 and $63.27. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 20:53 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 15,000 | $2.59 | $38,850.00 |
DisclosureSEC source: 0001209191-19-045769 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 20:14 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001209191-19-044799 · doc4.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,969 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 20:14 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 5,000 | $70.01 | $350,050.00 |
DisclosureSEC source: 0001209191-19-044799 · doc4.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16, 2019. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 20:14 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 5,000 | $18.86 | $94,300.00 |
DisclosureSEC source: 0001209191-19-044799 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 21:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 13,031 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001209191-19-041979 · doc4.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,969 Underlying: Common Stock · 13,031 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 21:43 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 13,031 | $70.04 | $912,691.24 |
DisclosureSEC source: 0001209191-19-041979 · doc4.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,991 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.